Td Private Client Wealth LLC Biomarin Pharmaceutical Inc Transaction History

Td Private Client Wealth LLC

  • $3.48 Trillion
  • Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 510 shares of BMRN stock, worth $33,797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
510
Previous 324 57.41%
Holding current value
$33,797
Previous $26.7 Million 34.39%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024
BUY
$69.02 - $93.84 $12,837 - $17,454
186 Added 57.41%
510 $35.8 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $24,115 - $29,879
324 New
324 $26.7 Million
Q1 2024

Aug 16, 2024
BUY
$83.81 - $99.0 $9,051 - $10,692
108 Added 76.6%
249 $21.7 Million
Q4 2023

Aug 16, 2024
BUY
$76.22 - $98.51 $1,829 - $2,364
24 Added 20.51%
141 $13.6 Million
Q3 2023

Aug 16, 2024
BUY
$85.07 - $94.48 $935 - $1,039
11 Added 10.38%
117 $10.4 Million
Q2 2023

Aug 16, 2024
BUY
$86.68 - $100.3 $2,253 - $2,607
26 Added 32.5%
106 $9.19 Million
Q1 2023

Aug 16, 2024
BUY
$87.74 - $117.27 $1,228 - $1,641
14 Added 21.21%
80 $7.78 Million
Q4 2022

Aug 16, 2024
BUY
$80.93 - $108.63 $809 - $1,086
10 Added 17.86%
66 $6.83 Million
Q1 2022

Aug 16, 2024
SELL
$74.28 - $92.69 $1,039 - $1,297
-14 Reduced 20.0%
56 $4.32 Million
Q4 2021

Aug 16, 2024
BUY
$71.72 - $91.47 $2,151 - $2,744
30 Added 75.0%
70 $6.19 Million
Q3 2021

Aug 16, 2024
SELL
$74.77 - $85.47 $21,234 - $24,273
-284 Reduced 87.65%
40 $3.09 Million
Q2 2021

Aug 16, 2024
BUY
$75.51 - $84.79 $830 - $932
11 Added 29.73%
48 $4.01 Million
Q1 2021

Aug 16, 2024
BUY
$74.73 - $90.69 $1,120 - $1,360
15 Added 68.18%
37 $2.79 Million
Q4 2020

Aug 16, 2024
BUY
$72.61 - $90.2 $290 - $360
4 Added 22.22%
22 $1.93 Million
Q3 2020

Aug 16, 2024
BUY
$71.87 - $131.03 $718 - $1,310
10 Added 125.0%
18 $1.37 Million
Q2 2020

Aug 16, 2024
SELL
$79.55 - $124.22 $2,147 - $3,353
-27 Reduced 77.14%
8 $987,000
Q4 2019

Aug 16, 2024
SELL
$64.27 - $86.37 $18,574 - $24,960
-289 Reduced 89.2%
35 $2.96 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email